← Leaderboards
Iakovos Toumazis
Stanford University
$2,388,418
Attributed
$2,388,418
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $668.9K · FY2017–25$1M$750K$500K$250K$0
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,388,418 · 2
By mechanism
R37$2,272,686 · 1
F32$115,732 · 1
Top collaborators
No co-investigators on record.
Most similar at Stanford University
Same institution · by research overlap
- Amy Michelle Padula$5,480,249
- Sylvia Katina Plevritis$44,733,712
- Maximilian Diehn$12,346,945
- Markus W Covert$9,997,943
- Billy W Loo$3,339,907
Others in their field
Other Emerging Leaders on “Malignant Neoplasms”
- Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
- Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
- Leonard Freedmand · Leidos Biomedical Research, Inc.$108,968,336
- Beverly Hayes · Leidos Biomedical Research, Inc.$98,336,166
- Martha Hering · Westat, Inc.$57,098,843
Research focus
Malignant NeoplasmsRadiation ExposureEffectivenessMalignant Neoplasm Of LungMortalityRaceDecision MakingEarly DiagnosisEligibility DeterminationLungDiagnosisModalityNatural HistoryCancer EtiologyCost EffectiveCostCost EffectivenessCancer PatientCancer RiskCessation Of LifeGuidelinesHealth BenefitDecision ModelingRecommendation
Grant awards (6)
Optimizing Personalized Screening and Diagnostic Decisions for Lung Cancer Based on Dynamic Risk Assessment and Life Expectancy$486,613
R37 · FY2025 · CA · contact PI
Optimizing Personalized Screening and Diagnostic Decisions for Lung Cancer Based on Dynamic Risk Assessment and Life Expectancy$502,013
R37 · FY2024 · CA · contact PI
Optimizing Personalized Screening and Diagnostic Decisions for Lung Cancer Based on Dynamic Risk Assessment and Life Expectancy$615,210
R37 · FY2023 · CA · contact PI
Optimizing Personalized Screening and Diagnostic Decisions for Lung Cancer Based on Dynamic Risk Assessment and Life Expectancy$668,850
R37 · FY2022 · CA · contact PI
Personalized, Dynamic Risk-based Lung Cancer Screening$59,038
F32 · FY2018 · CA · contact PI
Personalized, Dynamic Risk-based Lung Cancer Screening$56,694
F32 · FY2017 · CA · contact PI